Market Indices
Sector Heatmap
IFRX — InflaRx N.V. Common Stock
NasdaqInflaRx N.V. Common Stock
- O
- 1.69
- H
- 1.78
- L
- 1.57
- V
- 720.62K
IFRX — Latest News & Headlines
8 StoriesAn experimental drug showed promise in kidney disease models. InflaRx is set to present the findings at Kidney Week. - Stock Titan
An experimental drug showed promise in kidney disease models. InflaRx is set to present the findings at Kidney Week. Stock Titan
InflaRx N.V. Selected for Late-Breaking Kidney Week 2026 Poster on Izicopan Kidney Disease Models - Quiver Quantitative
InflaRx N.V. Selected for Late-Breaking Kidney Week 2026 Poster on Izicopan Kidney Disease Models Quiver Quantitative
A kidney specialist with more than two decades in pharma joins InflaRx - Stock Titan
A kidney specialist with more than two decades in pharma joins InflaRx Stock Titan
InflaRx appoints Gabriela Alperovich as head of clinical development By Investing.com - Investing.com Nigeria
InflaRx appoints Gabriela Alperovich as head of clinical development By Investing.com Investing.com Nigeria
IFOREX Financial Trading Holdings Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 - www.marketscreener.com
IFOREX Financial Trading Holdings Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 www.marketscreener.com
InflaRx presents kidney data and Needham raises InflaRx stock to Buy - AD HOC NEWS
InflaRx presents kidney data and Needham raises InflaRx stock to Buy AD HOC NEWS
iFOREX balances IPO milestone with profit pressure in first-half 2026 - TipRanks
iFOREX balances IPO milestone with profit pressure in first-half 2026 TipRanks
iFOREX Director and Audit Chair Joins Board of Nasdaq-Listed USA Rare Earth - TipRanks
iFOREX Director and Audit Chair Joins Board of Nasdaq-Listed USA Rare Earth TipRanks